We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

113 hedge funds and large institutions have $118M invested in iShares US Pharmaceuticals ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more call options, than puts

Call options by funds: $441K | Put options by funds: $206K

6.75% less ownership

Funds ownership: 99.65% → 92.89% (-6.8%)

10% less funds holding

Funds holding: 125 → 113 (-12)

10% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 30

18% less capital invested

Capital invested by funds: $143M → $118M (-$25.2M)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Holders
113
Holders Change
-12
Holders Change %
-9.6%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
27
Reduced
30
Closed
19
Calls
$441K
Puts
$206K
Net Calls
+$235K
Net Calls Change
+$235K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.15M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.32M
3
PGFC
Peapack-Gladstone Financial Corp
New Jersey
+$3.15M
4
Fisher Asset Management
Fisher Asset Management
Washington
+$2.48M
5
UBS Group
UBS Group
Switzerland
+$2.46M

Top Sellers

Rank Fund Capital Flow
1
EE
EWG Elevate
California
-$6.35M
2
RWP
RWA Wealth Partners
Massachusetts
-$5.05M
3
Goldman Sachs
Goldman Sachs
New York
-$3.92M
4
AWS
Atria Wealth Solutions
New York
-$3.22M
5
TRCT
Tower Research Capital (TRC)
New York
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
51
Cambridge Investment Research Advisors
Iowa
$263K +$27.5K +447 +11%
RMAM
52
Raab & Moskowitz Asset Management
New Jersey
$260K -$1.29K -21 -0.5%
KAS
53
Kestra Advisory Services
Texas
$259K -$21.6K -351 -7%
Qube Research & Technologies (QRT)
54
Qube Research & Technologies (QRT)
United Kingdom
$257K +$280K +4,551 New
CPC
55
Cookson Peirce & Co
Pennsylvania
$248K -$85.9K -1,395 -24%
NFC
56
Northeast Financial Consultants
Connecticut
$234K – – –
ASN
57
Advisory Services Network
Georgia
$233K -$19.8K -321 -7%
EFS
58
Essex Financial Services
Connecticut
$232K – – –
VWA
59
V Wealth Advisors
Kansas
$232K +$185 +3 +0.1%
AFC
60
AFT Forsyth & Company
Florida
$228K – – –
SFG
61
StrategIQ Financial Group
Indiana
$218K – – –
Cetera Investment Advisers
62
Cetera Investment Advisers
Illinois
$206K -$21.3K -345 -9%
MGIA
63
Matthew Goff Investment Advisor
Texas
$204K – – –
USCWA
64
U.S. Capital Wealth Advisors
Texas
$203K – – –
BLC
65
Brown, Lisle/Cummings
Rhode Island
$194K – – –
IA
66
IFP Advisors
Florida
$181K – – –
BAM
67
Belpointe Asset Management
Nevada
$141K +$370 +6 +0.2%
Northwestern Mutual Wealth Management
68
Northwestern Mutual Wealth Management
Wisconsin
$136K -$11.1K -180 -7%
Franklin Resources
69
Franklin Resources
California
$121K – – –
AWM
70
Angeles Wealth Management
California
$110K – – –
FDCDDQ
71
Federation des caisses Desjardins du Quebec
Quebec, Canada
$108K – – –
MAWCM
72
Mine & Arao Wealth Creation & Management
California
$94K – – –
AF
73
Allworth Financial
California
$87K +$185 +3 +0.2%
PNC Financial Services Group
74
PNC Financial Services Group
Pennsylvania
$57K – – –
VWM
75
Valley Wealth Managers
New Jersey
$51K – – –
1 2
3
4 5

IHE Hedge Fund Activity: Q3 2022 in Review

113 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2022, worth a combined $118M — down 18% from $143M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of IHE and 8 opened new positions — a net loss of 11 holders — while 30 trimmed existing stakes and 27 added.

The largest buyer was Susquehanna International Group, adding an estimated $4.15M. The largest seller was EWG Elevate, exiting entirely with an estimated $6.35M sold.

  • 113 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2022, down from 125 in Q2 2022.
  • Funds reported $118M of iShares US Pharmaceuticals ETF stock for Q3 2022, down 18% quarter-over-quarter.
  • 8 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2022 and 19 closed out, a net change of -11 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q3 2022 was Susquehanna International Group, an estimated $4.15M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q3 2022 was EWG Elevate, an estimated $6.35M sold.

Based on aggregated 13F filings for Q3 2022.